Kane Biotech (TSE:KNE) has released an update.
Kane Biotech has signed a five-year exclusive distribution agreement with XSONX to distribute its Wound Hygiene System in Canada, Australia, New Zealand, and GCC countries. This partnership aims to enhance Kane’s wound care product line and address the under-treatment of wounds in these markets. The agreement signifies a strategic move to expand Kane’s presence in the wound care sector.
For further insights into TSE:KNE stock, check out TipRanks’ Stock Analysis page.
